Opioid Exec John Kapoor Permanently Banned From U.S. Drug Work

Nov. 27, 2020, 4:37 PM UTC

Convicted opioid executive John Kapoor won’t be allowed to work on drugs regulated by the U.S. once his prison term ends.

The Food and Drug Administration posted a debarment notice Friday for Kapoor and a separate one for Barry J. Cadden, who founded a compounding pharmacy in Massachusetts linked to a nationwide meningitis outbreak. The permanent debarment notices prohibit both Kapoor and Cadden from “providing services in any capacity to a person that has an approved or pending drug product application.”

The notices fulfill an FDA statutory requirement to debar anyone who has been convicted of a felony related ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.